Skip to main content

Table 2 Distributions of the TNF-α genotypes and alleles among patients and controls

From: The role of Tumor necrosis factor alpha −308 G>A promoter polymorphism in pediatric community acquired pneumonia

 Patients (n = 45)Control (n = 45)OR (95% CI)p value
Genotype model
 AA4 (8.9%)2 (4.4%)1.6 (0.27–9.25)0.61
0.012a
 AG2 (4.4%)12 (26.7%)0.13 (0.03–0.63)
 GG39 (86.7%)31 (68.9%)Reference
Dominant model
 GG39 (86.7%)31 (68.9%)Reference0.048a
 AA+AG6 (13.3%)14 (31.1%)0.34 (0.12–0.99)
Recessive model
 AA4 (8.9%)2 (4.4%)2.09 (0.36–12.07)0.4
 AG+GG41 (91.1%)43 (95.6%)Reference
Alleles
 A10 (11.1%)16 (17.7%)0.58 (0.25–1.35)0.21
 G80 (88.8%)74 (82.2%)Reference
  1. Data is expressed a number (percentage)
  2. OR odds ratio, 95% CI confidence interval
  3. aStatistically significant